Horizon Therapeutics (NASDAQ:HZNP) has priced its public offering of 11.8M ordinary shares at $71.00/share, for expected net proceeds of ~$798.9M. Underwri
seekingalpha · 1天前
Horizon Therapeutics Named 2020 Top Workplace for Millennials by Fortune
Horizon Therapeutics plc (NASDAQ: HZNP) today announced that it has been named to the 2020 Fortune Best Workplaces for Millennials™ list. Horizon ranked 7th among 25 companies in the small and medium company category in its first year on the list.
Business Wire · 2天前
Horizon Therapeutics plc Announces Proposed Public Offering of Ordinary Shares
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it is offering to sell $700,000,000 of its ordinary shares in an underwritten public offering. The Company also expects to grant the underwriters a 30-day option to purchase up to an additional $105,
Business Wire · 3天前
Why Horizon Therapeutics Stock Is Up Today
Shares of Horizon Therapeutics (NASDAQ: HZNP) are up by 17% as of 11:54 a.m. EDT on Wednesday, after the company reported better-than-expected second-quarter financial results before the market opened today. During the second quarter, Horizon Therapeutics' ne
Motley Fool · 3天前
Recap: Horizon Therapeutics Q2 Earnings
Shares of Horizon Therapeutics (NASDAQ:HZNP) were unchanged after the company reported Q2 results.Quarterly Results Earnings per share fell 18.37% over the past year to $0.40, which beat the estimate of $0.34.Revenue of $462,779,000 up by 44.33% from the same
Benzinga · 3天前
Horizon Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. The company also raised its FY20 sales guidance above analyst estimates.
Benzinga · 3天前
Horizon Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. The company also raised its FY20 sales guidance above analyst estimates.
Benzinga · 3天前
Horizon Therapeutics Raises FY20 Sales Guidance From $1.40B-$1.45B To $1.85B-$1.90B vs $1.54B Est.